Studying the heart's electrical signals in ventricular tachycardia
Tests a catheter measuring heart tissue's electrical activity in adults with ventricular tachycardia.
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the 3 sites
- Trial code
- Registry title
- Ventricular Tachycardia Mechanisms
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 25 Oct 2022
- Expected to end
- May 2027
- Type of study
- Interventional
- Treatments tested
- Monophasic Action Potential (MAP) Catheter
- Record updated
- 30 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with ischemic cardiomyopathy who have an ICD and are having a ventricular tachycardia (VT) ablation. Ischemic cardiomyopathy is heart muscle damage from poor blood flow.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Ischemic cardiomyopathy (heart muscle damage caused by reduced blood flow to the heart).
- Earlier treatment
- Must have a single or dual chamber implantable cardioverter-defibrillator (ICD), a device that shocks the heart back to a normal rhythm.
Main reasons for not taking part
- Non-ischemic cardiomyopathy
- A reason you cannot have catheter ablation
- Severe peripheral arterial disease or another condition that blocks access through an artery
- VT or sudden cardiac arrest within 30 days of acute coronary syndrome (heart attack or unstable angina)
- VT or sudden cardiac arrest within 90 days of a procedure to reopen heart arteries
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Diagnosis of ischemic cardiomyopathy
- Single or dual chamber implantable cardioverter-defibrillator (ICD)
Who cannot take part
- Severe peripheral arterial disease or medical condition that prohibit arterial access
- Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization
- Non-Ischemic cardiomyopathy
- Contraindication to catheter ablation
Where in United States
- Emory ClinicAtlanta, United StatesContact: Neal Bhatia, MDTaking people
- Emory University HospitalAtlanta, United StatesContact: Neal Bhatia, MDTaking people
- Emory University Hospital MidtownAtlanta, United StatesContact: Neal Bhatia, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.
The group in the trial
- Monophasic Action Potential (MAP) CatheterTreatment being tested
Participants undergoing ventricular tachycardia ablation per standard of care will also have cellular action potential of the ventricular myocardium assessed with the MAP catheter.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters
- Plain-language title
- Studying the heart's electrical signals in ventricular tachycardiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 30 June 2026